News and Position Papers
News
22.05.2026
EFCG Position Paper on the Global Health Resilience Initiative
EFCG, the European Fine Chemicals Group representing the European manufacturers of fine chemicals including Active Pharmaceutical Ingredients (APIs), excipients and intermediates, welcomes the…
19.05.2026
Strengthening Europe’s Health Biomanufacturing Value Chains with the Biotech Act I – May 2026
The European Fine Chemicals Group (EFCG), a sector group of Cefic representing the European manufacturers of fine chemicals including Active…
13.05.2026
EFCG Position Paper on the provisional agreement on the CMA
The European Fine Chemicals Group (EFCG) welcomes the provisional agreement reached between the European Council and the European Parliament on the Critical…
21.01.2026
EFCG welcomes the European Parliament’s Commitment to a Strong Critical Medicines Act
The European Fine Chemicals Group (EFCG) welcomes the European Parliament’s position on the Critical Medicines Act (CMA), a landmark initiative…
18.12.2025
The Strategic Role of CDMOs in Europe’s Biopharmaceuticals future
EFCG calls on policymakers to decisively imbed Contract Development and Manufacturing Organizations (CDMOs) within the Biotech Act’s implementation roadmap. This…
19.11.2025
Call for Action – Critical Medicines Act
Europe faces a pivotal moment in its ability to provide essential medicines to its citizens. The Critical Medicines Act (CMA)…
14.03.2023
Article in Chemistry Today – Chimica Oggi
In the past three years, EFCG relentlessly strove to alert EU authorities on the need to address head-on the root…
09.11.2022
A strong European API Industry can achieve strategic autonomy of the EU Health System
Europe needs a strong EU-based API industry to achieve strategic autonomy for its health system. The COVID-19 pandemic highlighted the…